US6303301B1
(en)
*
|
1997-01-13 |
2001-10-16 |
Affymetrix, Inc. |
Expression monitoring for gene function identification
|
US6355430B1
(en)
*
|
1998-12-24 |
2002-03-12 |
Millennium Pharmaceuticals, Inc. |
Diagnostic and screening methods employing KIAA0101
|
US6936424B1
(en)
|
1999-11-16 |
2005-08-30 |
Matritech, Inc. |
Materials and methods for detection and treatment of breast cancer
|
EP1257663A2
(de)
*
|
2000-02-22 |
2002-11-20 |
Oxford Biomedica (UK) Limited |
Differentielle expressions screeningverfahren
|
US6884578B2
(en)
|
2000-03-31 |
2005-04-26 |
Affymetrix, Inc. |
Genes differentially expressed in secretory versus proliferative endometrium
|
CA2408011A1
(en)
|
2000-05-04 |
2001-11-08 |
Avi Biopharma, Inc. |
Splice-region antisense composition and method
|
US7700359B2
(en)
*
|
2000-06-02 |
2010-04-20 |
Novartis Vaccines And Diagnostics, Inc. |
Gene products differentially expressed in cancerous cells
|
WO2002002819A1
(en)
*
|
2000-06-30 |
2002-01-10 |
University Of Utah Research Foundation |
Method of screening for chemotherapeutic treatments for cancer
|
US7567870B1
(en)
*
|
2000-07-31 |
2009-07-28 |
Institute For Systems Biology |
Multiparameter analysis for predictive medicine
|
DE10037769A1
(de)
*
|
2000-08-03 |
2002-02-21 |
Epigenomics Gmbh |
Diagnose von mit CD24 assoziierten Krankheiten
|
US7807447B1
(en)
|
2000-08-25 |
2010-10-05 |
Merck Sharp & Dohme Corp. |
Compositions and methods for exon profiling
|
US6713257B2
(en)
*
|
2000-08-25 |
2004-03-30 |
Rosetta Inpharmatics Llc |
Gene discovery using microarrays
|
US7108969B1
(en)
*
|
2000-09-08 |
2006-09-19 |
Affymetrix, Inc. |
Methods for detecting and diagnosing oral cancer
|
GB0022978D0
(en)
|
2000-09-19 |
2000-11-01 |
Oxford Glycosciences Uk Ltd |
Detection of peptides
|
US6780594B2
(en)
|
2000-09-25 |
2004-08-24 |
Schering Aktiengesellschaft |
Method for in vitro diagnosis of endometriosis
|
DE10048633A1
(de)
*
|
2000-09-25 |
2002-04-18 |
Schering Ag |
Methode zur in vitro Diagnostik von Endometriose
|
US6743897B1
(en)
|
2000-11-27 |
2004-06-01 |
Cytokinetics, Inc. |
Aspergillus fumigatus profilin
|
US6403372B1
(en)
|
2000-11-27 |
2002-06-11 |
Cytokinetics, Inc. |
Aspergillus fumigatus profilin
|
DK1402073T3
(da)
*
|
2001-06-05 |
2007-06-11 |
Auckland Uniservices Ltd |
Fremgangsmåder og præparater til vurdering af lungefunktion og -lidelser
|
DE60237917D1
(de)
*
|
2001-06-05 |
2010-11-18 |
Exelixis Inc |
Gfats als modifikatoren des p53-wegs und verwendungsverfahren
|
US6924113B2
(en)
|
2001-06-08 |
2005-08-02 |
Panomics, Inc. |
Method and kit for isolating DNA probes that bind to activated transcription factors
|
US7981842B2
(en)
|
2001-06-08 |
2011-07-19 |
Panomics, Inc. |
Method for detecting transcription factor-protein interactions
|
US20040214166A1
(en)
*
|
2001-06-08 |
2004-10-28 |
Xianqiang Li |
Method for identifying a disease state based on a detected mixture of activated transcription factors
|
US6821737B2
(en)
|
2001-06-08 |
2004-11-23 |
Panomics, Inc. |
Method for screening for drug candidates for modulating transcription factor activity
|
US6696256B1
(en)
|
2001-06-08 |
2004-02-24 |
Pandmics, Inc. |
Method, array and kit for detecting activated transcription factors by hybridization array
|
US7343247B2
(en)
*
|
2001-07-30 |
2008-03-11 |
The Institute For Systems Biology |
Methods of classifying drug responsiveness using multiparameter analysis
|
AU2002336410A1
(en)
*
|
2001-08-29 |
2003-09-09 |
The Board Of Trustees Of The University Of Illinois |
Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
|
US7781413B2
(en)
*
|
2001-10-31 |
2010-08-24 |
Board Of Regents, The University Of Texas System |
SEMA3B inhibits tumor growth and induces apoptosis in cancer cells
|
EP1458486B1
(de)
*
|
2001-12-19 |
2008-09-17 |
Affymetrix, Inc. |
Arrayplatten und verfahren zur herstellung von arrayplatten
|
US20030175713A1
(en)
*
|
2002-02-15 |
2003-09-18 |
Clemens Sorg |
Method for diagnosis of inflammatory diseases using CALGRANULIN C
|
US20040096874A1
(en)
*
|
2002-04-11 |
2004-05-20 |
Third Wave Technologies, Inc. |
Characterization of CYP 2D6 genotypes
|
US7504215B2
(en)
|
2002-07-12 |
2009-03-17 |
Affymetrix, Inc. |
Nucleic acid labeling methods
|
AU2003259795A1
(en)
*
|
2002-08-19 |
2004-03-03 |
Yun Yen |
Treatment of liver deseases
|
US8008003B2
(en)
*
|
2002-11-15 |
2011-08-30 |
Genomic Health, Inc. |
Gene expression profiling of EGFR positive cancer
|
US20040231909A1
(en)
|
2003-01-15 |
2004-11-25 |
Tai-Yang Luh |
Motorized vehicle having forward and backward differential structure
|
JP2006521793A
(ja)
*
|
2003-02-06 |
2006-09-28 |
ゲノミック ヘルス, インコーポレイテッド |
Egfrインヒビター薬物に応答性の遺伝子発現マーカー
|
DK1597391T3
(da)
*
|
2003-02-20 |
2009-01-12 |
Genomic Health Inc |
Anvendelse af intron-RNA til måling af genekspression
|
WO2004111273A2
(en)
*
|
2003-05-30 |
2004-12-23 |
Genomic Health, Inc. |
Gene expression markers for response to egfr inhibitor drugs
|
EP2327796A1
(de)
|
2003-06-10 |
2011-06-01 |
The Trustees Of Boston University |
Nachweismethoden für Lungenerkrankungen
|
ES2488845T5
(es)
|
2003-06-24 |
2017-07-11 |
Genomic Health, Inc. |
Predicción de la probabilidad de recidiva de cáncer
|
EP1644858B1
(de)
*
|
2003-07-10 |
2017-12-06 |
Genomic Health, Inc. |
Expressions-profil-algorithmus und test auf krebsprognose
|
US7425544B2
(en)
|
2003-09-18 |
2008-09-16 |
Eli Lilly And Company |
Modulation of eIF4E expression
|
AU2004284434A1
(en)
*
|
2003-10-16 |
2005-05-06 |
Genomic Health, Inc. |
qRT-PCR assay system for gene expression profiling
|
US20050196782A1
(en)
*
|
2003-12-23 |
2005-09-08 |
Kiefer Michael C. |
Universal amplification of fragmented RNA
|
US20050191682A1
(en)
|
2004-02-17 |
2005-09-01 |
Affymetrix, Inc. |
Methods for fragmenting DNA
|
US7157233B2
(en)
|
2004-03-24 |
2007-01-02 |
Tripath Imaging, Inc. |
Methods and compositions for the detection of cervical disease
|
JP5813908B2
(ja)
|
2004-04-09 |
2015-11-17 |
ジェノミック ヘルス, インコーポレイテッド |
化学療法剤に対する応答を予測するための遺伝子発現マーカー
|
US20060073506A1
(en)
|
2004-09-17 |
2006-04-06 |
Affymetrix, Inc. |
Methods for identifying biological samples
|
WO2006034278A2
(en)
*
|
2004-09-21 |
2006-03-30 |
Matritech, Inc. |
Methods and compositions for detecting cancer using components of the u2 spliceosomal particle
|
US20060073511A1
(en)
|
2004-10-05 |
2006-04-06 |
Affymetrix, Inc. |
Methods for amplifying and analyzing nucleic acids
|
NZ554438A
(en)
*
|
2004-10-14 |
2009-11-27 |
Genentech Inc |
COP1 molecules and uses thereof
|
US7682782B2
(en)
|
2004-10-29 |
2010-03-23 |
Affymetrix, Inc. |
System, method, and product for multiple wavelength detection using single source excitation
|
CA2524964A1
(en)
|
2004-10-29 |
2006-04-29 |
Affymetrix, Inc. |
Automated method of manufacturing polymer arrays
|
DK1815014T3
(da)
*
|
2004-11-05 |
2012-06-18 |
Genomic Health Inc |
Molekylære indikatorer for brystcancerprognose og forudsigelse af behandlingsrespons
|
US7930104B2
(en)
|
2004-11-05 |
2011-04-19 |
Genomic Health, Inc. |
Predicting response to chemotherapy using gene expression markers
|
US7957507B2
(en)
|
2005-02-28 |
2011-06-07 |
Cadman Patrick F |
Method and apparatus for modulating a radiation beam
|
CA2605158A1
(en)
|
2005-04-14 |
2006-10-26 |
The Trustees Of Boston University |
Diagnostic for lung disorders using class prediction
|
EP1896607A4
(de)
*
|
2005-05-10 |
2009-12-16 |
Synergenz Bioscience Ltd |
Verfahren und zusammensetzungen zur beurteilung der lungenfunktion und von lungenerkrankungen
|
US8232535B2
(en)
|
2005-05-10 |
2012-07-31 |
Tomotherapy Incorporated |
System and method of treating a patient with radiation therapy
|
ES2429564T3
(es)
|
2005-05-18 |
2013-11-15 |
Novartis Ag |
Procedimientos para el diagnóstico y tratamiento de enfermedades que tienen un componente autoinmune y/o inflamatorio
|
WO2006123954A1
(en)
*
|
2005-05-19 |
2006-11-23 |
Synergenz Bioscience Limited |
Methods and compositions for assessment of pulmonary function and disorders
|
CA2608161A1
(en)
*
|
2005-05-19 |
2006-11-23 |
Synergenz Bioscience Limited |
Methods for the assesssment of risk of developing lung cancer using analysis of genetic polymorphisms
|
AU2006248189A1
(en)
*
|
2005-05-20 |
2006-11-23 |
Synergenz Bioscience Limited |
Methods of analysis of polymorphisms and uses thereof
|
US20070195922A1
(en)
*
|
2005-07-22 |
2007-08-23 |
Mackie Thomas R |
System and method of monitoring the operation of a medical device
|
KR20080039920A
(ko)
*
|
2005-07-22 |
2008-05-07 |
토모테라피 인코포레이티드 |
방사선 치료 시스템에 의해 부여되는 선량을 평가하는시스템 및 방법
|
KR20080049716A
(ko)
|
2005-07-22 |
2008-06-04 |
토모테라피 인코포레이티드 |
치료 계획의 전달과 관련된 퀄리티 보증 기준을 평가하는방법 및 시스템
|
EP2532386A3
(de)
*
|
2005-07-22 |
2013-02-20 |
TomoTherapy, Inc. |
System zur Verabreichung einer Strahlentherapie auf ein sich bewegendes Interessengebiet
|
EP1907981A4
(de)
*
|
2005-07-22 |
2009-10-21 |
Tomotherapy Inc |
Verfahren und system zur beurteilung einer verabreichten dosis
|
KR20080039925A
(ko)
*
|
2005-07-22 |
2008-05-07 |
토모테라피 인코포레이티드 |
생물학적 모델에 기초하여 방사선 요법 치료 계획을적합화시키는 방법 및 시스템
|
ATE507879T1
(de)
*
|
2005-07-22 |
2011-05-15 |
Tomotherapy Inc |
System zur verabreichung einer strahlentherapie auf ein sich bewegendes zielgebiet
|
US8442287B2
(en)
|
2005-07-22 |
2013-05-14 |
Tomotherapy Incorporated |
Method and system for evaluating quality assurance criteria in delivery of a treatment plan
|
KR20080044252A
(ko)
*
|
2005-07-22 |
2008-05-20 |
토모테라피 인코포레이티드 |
방사선 요법 치료 계획에 관한 데이터의 처리 방법 및시스템
|
CA2616299A1
(en)
*
|
2005-07-22 |
2007-02-01 |
Tomotherapy Incorporated |
Method of placing constraints on a deformation map and system for implementing same
|
CA2616293A1
(en)
|
2005-07-23 |
2007-02-01 |
Tomotherapy Incorporated |
Radiation therapy imaging and delivery utilizing coordinated motion of gantry and couch
|
US20070092891A1
(en)
*
|
2005-09-02 |
2007-04-26 |
Willey James C |
Methods and compositions for identifying biomarkers useful in diagnosis and/or treatment of biological states
|
EP1941057A4
(de)
*
|
2005-10-07 |
2009-11-11 |
Baylor Res Inst |
Diagnose des systemischen ausbruchs juveniler idiopathischer arthritis über blutleukozyten-mikroarrayanalyse
|
US7846664B2
(en)
*
|
2005-12-07 |
2010-12-07 |
The Regents Of The University Of California |
Diagnosis and treatment of chronic lymphocytic leukemia (CLL)
|
US7634363B2
(en)
|
2005-12-07 |
2009-12-15 |
Affymetrix, Inc. |
Methods for high throughput genotyping
|
EP1969506A1
(de)
*
|
2005-12-13 |
2008-09-17 |
Erasmus University Medical Center Rotterdam |
Genetische hirntumor-markierer
|
WO2007090076A2
(en)
|
2006-01-27 |
2007-08-09 |
Tripath Imaging, Inc. |
Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor
|
AU2007223788B2
(en)
|
2006-03-09 |
2012-11-29 |
The Trustees Of Boston University |
Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells
|
EP2389946A1
(de)
|
2006-03-23 |
2011-11-30 |
Novartis AG |
Antitumorzellenantigen-Antikörper-Therapeutika
|
AU2007284651B2
(en)
|
2006-08-09 |
2014-03-20 |
Institute For Systems Biology |
Organ-specific proteins and methods of their use
|
WO2008024114A1
(en)
*
|
2006-08-24 |
2008-02-28 |
Genizon Biosciences Inc. |
Genemap of the human genes associated with schizophrenia
|
US20100267575A1
(en)
*
|
2006-10-17 |
2010-10-21 |
Childrens Hospital Medical Center |
Gene array technique for predicting response in inflammatory bowel diseases
|
US9845494B2
(en)
|
2006-10-18 |
2017-12-19 |
Affymetrix, Inc. |
Enzymatic methods for genotyping on arrays
|
NZ598954A
(en)
|
2006-11-03 |
2012-10-26 |
Baylor Res Inst |
Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte microarray analysis
|
US8293684B2
(en)
*
|
2006-11-29 |
2012-10-23 |
Exiqon |
Locked nucleic acid reagents for labelling nucleic acids
|
US8200440B2
(en)
|
2007-05-18 |
2012-06-12 |
Affymetrix, Inc. |
System, method, and computer software product for genotype determination using probe array data
|
US9012370B2
(en)
|
2008-03-11 |
2015-04-21 |
National Cancer Center |
Method for measuring chromosome, gene or specific nucleotide sequence copy numbers using SNP array
|
GB0809069D0
(en)
|
2008-05-19 |
2008-06-25 |
Univ Leuven Kath |
Gene signatures
|
WO2009158143A1
(en)
|
2008-05-30 |
2009-12-30 |
The University Of North Carolina At Chapel Hill |
Gene expression profiles to predict breast cancer outcomes
|
EP3255146B1
(de)
|
2009-03-16 |
2019-05-15 |
Pangu Biopharma Limited |
Zusammensetzungen und verfahren mit histidyl-trna-synthetase-spleissvarianten mit nicht-kanonischen biologischen aktivitäten
|
US20100310576A1
(en)
|
2009-03-31 |
2010-12-09 |
Adams Ryan A |
COMPOSITIONS AND METHODS COMPRISING ASPARTYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES
|
EP2488873B1
(de)
|
2009-10-16 |
2015-08-05 |
Novartis AG |
Biomarker für pharmakodynamische tumorreaktionen
|
CN102640001A
(zh)
|
2009-11-05 |
2012-08-15 |
诺瓦提斯公司 |
预测纤维化进展的生物标记物
|
US8501122B2
(en)
|
2009-12-08 |
2013-08-06 |
Affymetrix, Inc. |
Manufacturing and processing polymer arrays
|
US8835358B2
(en)
|
2009-12-15 |
2014-09-16 |
Cellular Research, Inc. |
Digital counting of individual molecules by stochastic attachment of diverse labels
|
WO2011079280A2
(en)
|
2009-12-23 |
2011-06-30 |
Hill's Pet Nutrition, Inc. |
Compositions and methods for diagnosing and treating kidney disorders in a canine
|
MX2012009318A
(es)
|
2010-02-10 |
2012-09-07 |
Novartis Ag |
Metodos y compuestos para el crecimiento muscular.
|
US8383793B2
(en)
|
2010-04-15 |
2013-02-26 |
St. Jude Children's Research Hospital |
Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors
|
JP6066900B2
(ja)
|
2010-04-26 |
2017-01-25 |
エータイアー ファーマ, インコーポレイテッド |
システイニルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
CA2797362C
(en)
|
2010-04-27 |
2020-12-08 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases
|
JP6008837B2
(ja)
|
2010-04-28 |
2016-10-19 |
エータイアー ファーマ, インコーポレイテッド |
アラニルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
CA2797393C
(en)
|
2010-04-29 |
2020-03-10 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
|
WO2011150279A2
(en)
|
2010-05-27 |
2011-12-01 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
|
WO2011139854A2
(en)
|
2010-04-29 |
2011-11-10 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases
|
EP2566495B1
(de)
|
2010-05-03 |
2017-03-01 |
aTyr Pharma, Inc. |
Innovative entdeckung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen im zusammenhang mit proteinfragmenten von phenylalanyl-alpha-trna-synthetasen
|
JP6008841B2
(ja)
|
2010-05-03 |
2016-10-19 |
エータイアー ファーマ, インコーポレイテッド |
メチオニルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
CA2797277C
(en)
|
2010-05-03 |
2021-02-23 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
|
EP2566499B1
(de)
|
2010-05-04 |
2017-01-25 |
aTyr Pharma, Inc. |
Innovative entdeckung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen im zusammenhang mit proteinfragmenten aus einem p38-multi-trna-synthetase-komplex
|
CN103200953B
(zh)
|
2010-05-14 |
2017-02-15 |
Atyr 医药公司 |
与苯丙氨酰‑β‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
JP6027965B2
(ja)
|
2010-05-17 |
2016-11-16 |
エータイアー ファーマ, インコーポレイテッド |
ロイシルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
WO2011150400A1
(en)
*
|
2010-05-28 |
2011-12-01 |
New York Blood Center, Inc. |
Nuclear scaffold protein stip/tfip11 target for cancer therapy
|
WO2011153277A2
(en)
|
2010-06-01 |
2011-12-08 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
|
CA2800913C
(en)
|
2010-06-03 |
2019-07-23 |
Pharmacyclics, Inc. |
The use of inhibitors of bruton's tyrosine kinase (btk)
|
JP2013529089A
(ja)
|
2010-06-07 |
2013-07-18 |
エフ.ホフマン−ラ ロシュ アーゲー |
インターロイキン−6受容体を阻害するモノクローナル抗体による薬剤治療に対する応答を予測するための遺伝子発現マーカー
|
AU2011289831C1
(en)
|
2010-07-12 |
2017-06-15 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
|
JP6047489B2
(ja)
|
2010-08-12 |
2016-12-21 |
フェイト セラピューティクス,インコーポレイテッド |
改善された造血幹細胞および前駆細胞療法
|
EP2608801B1
(de)
|
2010-08-25 |
2019-08-21 |
aTyr Pharma, Inc. |
Innovative erkennung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen in zusammenhang mit proteinfragmenten von tyrosyl-trna-synthetasen
|
US9574173B2
(en)
|
2010-11-15 |
2017-02-21 |
Accelerated Biosciences Corp. |
Generation of neural stem cells from human trophoblast stem cells
|
CA2819378A1
(en)
|
2010-12-02 |
2012-06-07 |
Katholieke Universiteit Leuven, K.U.Leuven R&D |
Irak-related interventions and diagnosis
|
EP3062108B1
(de)
|
2011-02-24 |
2019-06-19 |
Hill's Pet Nutrition, Inc. |
Verfahren zur diagnostizierung von nierenerkrankungen bei katzen
|
MY181093A
(en)
|
2011-03-02 |
2020-12-17 |
Berg Llc |
Interrogatory cell-based assays and uses thereof
|
WO2012119077A1
(en)
|
2011-03-02 |
2012-09-07 |
Morphotek Inc. |
Co -administration of eribulin and farletuzumab for the treatment of breast cancer
|
CA2830240A1
(en)
|
2011-03-15 |
2012-09-20 |
The University Of North Carolina At Chapell Hill |
Methods of treating breast cancer with anthracycline therapy
|
SG10201602147YA
(en)
|
2011-03-18 |
2016-05-30 |
Eisai R&D Man Co Ltd |
Methods And Compositions For Predicting Response To Eribulin
|
WO2012134813A1
(en)
|
2011-03-31 |
2012-10-04 |
St. Jude Children's Research Hospital |
Methods and compositions for identifying minimal residual disease in acute lymphoblastic leukemia
|
AU2012271528B2
(en)
|
2011-06-15 |
2015-06-25 |
Hill's Pet Nutrition, Inc. |
Compositions and methods for diagnosing and monitoring hyperthyroidism in a feline
|
WO2013080050A2
(en)
|
2011-11-30 |
2013-06-06 |
Universitaetsklinikum Erlangen |
Methods and compositions for determining responsiveness to treatment with a tnf-alpha inhibitor
|
JP6189857B2
(ja)
|
2011-12-19 |
2017-08-30 |
ヒルズ・ペット・ニュートリシャン・インコーポレーテッド |
伴侶動物において甲状腺機能亢進症を診断および治療するための組成物および方法
|
KR20140123571A
(ko)
|
2012-02-16 |
2014-10-22 |
에이티와이알 파마, 인코포레이티드 |
자가면역 및 염증성 질환의 치료를 위한 히스티딜trna 신테타제
|
EP2820174B1
(de)
|
2012-02-27 |
2019-12-25 |
The University of North Carolina at Chapel Hill |
Verfahren und verwendung für molekulare tags
|
ES2663234T3
(es)
|
2012-02-27 |
2018-04-11 |
Cellular Research, Inc |
Composiciones y kits para recuento molecular
|
BR112014024537A2
(pt)
|
2012-04-02 |
2017-08-08 |
Berg Llc |
métodos para identificar moduladores de um sistema biológico, de um processo de doença, e de angiogênese
|
AU2013243300B2
(en)
|
2012-04-05 |
2018-12-06 |
Oregon Health & Science University |
Gene expression panel for breast cancer prognosis
|
EP2852689B1
(de)
|
2012-05-22 |
2019-12-11 |
Nanostring Technologies, Inc. |
Nano46-gene und verfahren zur vorhersage von brustkrebsergebnissen
|
EP2877598A1
(de)
|
2012-07-24 |
2015-06-03 |
Pharmacyclics, Inc. |
Mutationen im zusammenhang mit der resistenz gegenüber hemmern der bruton-tyrosinkinase (btk)
|
JP6309019B2
(ja)
|
2012-11-27 |
2018-04-11 |
ポンティフィシア・ウニベルシダッド・カトリカ・デ・チレPontificia Universidad Catolica de Chile |
甲状腺腫瘍を診断するための組成物および方法
|
EP3591036B1
(de)
|
2012-11-30 |
2023-03-22 |
Accelerated BioSciences Corp. |
Verfahren zur differenzierung von stammzellen durch modulation von mir-124
|
MX2015009392A
(es)
|
2013-01-21 |
2015-10-15 |
Abbvie Inc |
Biomarcadores de terapia de combinacion anti-tnf y anti-il17 para enfermedades inflamatorias.
|
US9443633B2
(en)
|
2013-02-26 |
2016-09-13 |
Accuray Incorporated |
Electromagnetically actuated multi-leaf collimator
|
CA3175634A1
(en)
|
2013-02-28 |
2014-09-04 |
Caprion Proteomics Inc. |
Tuberculosis biomarkers and uses thereof
|
AU2014317843A1
(en)
|
2013-09-09 |
2016-03-24 |
British Columbia Cancer Agency Branch |
Methods and kits for predicting outcome and methods and kits for treating breast cancer with radiation therapy
|
KR102392423B1
(ko)
|
2013-10-02 |
2022-05-02 |
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 |
Wnt 조성물 및 정제 방법
|
US10704097B2
(en)
|
2014-02-27 |
2020-07-07 |
Katholieke Universiteit Leuven |
Oxidative stress and cardiovascular disease events
|
WO2015127517A1
(en)
|
2014-02-27 |
2015-09-03 |
Katholieke Universiteit Leuven |
Oxidative stress and cardiovascular disease events
|
WO2015143400A1
(en)
|
2014-03-20 |
2015-09-24 |
Pharmacyclics, Inc. |
Phospholipase c gamma 2 and resistance associated mutations
|
US10829819B2
(en)
|
2014-05-30 |
2020-11-10 |
Genecentric Therapeutics, Inc. |
Methods for typing of lung cancer
|
US20160000936A1
(en)
|
2014-06-10 |
2016-01-07 |
Abbvie Inc. |
Biomarkers for inflammatory disease and methods of using same
|
CN108064380A
(zh)
|
2014-10-24 |
2018-05-22 |
皇家飞利浦有限公司 |
使用多种细胞信号传导途径活性的医学预后和治疗反应的预测
|
CN108064311B
(zh)
|
2014-10-24 |
2022-10-28 |
皇家飞利浦有限公司 |
使用多种细胞信号传导途径活性的治疗反应的医学预后和预测
|
JP6415712B2
(ja)
|
2014-10-24 |
2018-10-31 |
コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. |
標的遺伝子発現の数学的モデル化を用いるTGF−β細胞シグナル伝達経路活性の評価
|
GB2548059B
(en)
|
2014-11-26 |
2020-09-02 |
Accelerated Biosciences Corp |
Induced hepatocytes and uses thereof
|
US10196693B2
(en)
|
2014-12-12 |
2019-02-05 |
Medivation Prostate Therapeutics Llc |
Method for predicting response to breast cancer therapeutic agents and method of treatment of breast cancer
|
EP3234112B1
(de)
|
2014-12-19 |
2019-12-11 |
Vrije Universiteit Brussel |
In-vitro-reifung eines säuger-cumulus-oozyten-komplexes
|
JP2016214239A
(ja)
*
|
2015-05-15 |
2016-12-22 |
国立大学法人高知大学 |
膵がんマーカー
|
US10066229B2
(en)
|
2015-07-28 |
2018-09-04 |
Otonomy, Inc. |
Treatment using truncated Trk B and Trk C antagonists
|
ES2861400T3
(es)
|
2015-08-14 |
2021-10-06 |
Koninklijke Philips Nv |
Evaluación de la actividad de la ruta de señalización celular de NFkB usando modelos matemáticos de la expresión de genes diana
|
US20180305748A1
(en)
|
2015-10-18 |
2018-10-25 |
Affymetrix, Inc. |
Multiallelic Genotyping of Single Nucleotide Polymorphisms and Indels
|
KR20170076480A
(ko)
|
2015-12-24 |
2017-07-04 |
삼성전자주식회사 |
Pint 유전자의 발현 저해제 또는 pint의 활성 저해제를 포함하는 조성물 및 그의 용도
|
CN116509869A
(zh)
|
2016-04-04 |
2023-08-01 |
希诺皮亚生物科学公司 |
使用曲匹地尔治疗锥体外系综合征
|
EP3458611B1
(de)
|
2016-05-17 |
2023-11-08 |
Genecentric Therapeutics, Inc. |
Verfahren zur subtypisierung von plattenzellkarzinomen
|
CA3024747A1
(en)
|
2016-05-17 |
2017-11-23 |
Genecentric Therapeutics, Inc. |
Methods for subtyping of lung adenocarcinoma
|
EP3260552A1
(de)
|
2016-06-20 |
2017-12-27 |
Istituto Europeo di Oncologia (IEO) |
Verfahren und kits mit gensignaturen zur stratifizierung von brustkrebspatienten
|
WO2018013883A1
(en)
|
2016-07-14 |
2018-01-18 |
Caprion Proteomics Inc. |
Biomarkers of latent tuberculosis infection
|
WO2018015375A1
(en)
|
2016-07-20 |
2018-01-25 |
Westfälische Wilhelms-Universität Münster |
Complex-specific standardization of immunological methods for the quantification of s100a12
|
EP3655418A4
(de)
|
2017-06-22 |
2021-05-19 |
Triact Therapeutics, Inc. |
Verfahren zur behandlung von glioblastom
|
US11739386B2
(en)
|
2017-07-21 |
2023-08-29 |
Genecentric Therapeutics, Inc. |
Methods for determining response to PARP inhibitors
|
US11628144B2
(en)
|
2017-09-29 |
2023-04-18 |
Triact Therapeutics, Inc. |
Iniparib formulations and uses thereof
|
EP3461915A1
(de)
|
2017-10-02 |
2019-04-03 |
Koninklijke Philips N.V. |
Beurteilung der aktivität von zellulären jak-stat1/2-signalisierungspfaden mittels mathematischer modellierung der zielgenexpression
|
EP3502279A1
(de)
|
2017-12-20 |
2019-06-26 |
Koninklijke Philips N.V. |
Beurteilung der aktivität von zellulären mapk-ap 1-signalisierungspfaden mittels mathematischer modellierung der zielgenexpression
|
WO2019178606A1
(en)
|
2018-03-16 |
2019-09-19 |
Gopath Laboratories Llc |
Methods for personalized detection of the recurrence of cancer or metastasis and/or evaluation of treatment response
|
US20210343368A1
(en)
|
2018-09-05 |
2021-11-04 |
Max-Delbrück-Centrum Für Molekulare Medizin In Der Helmholtz-Gemeinschaft |
Method for Engineering Synthetic Cis-Regulatory DNA
|
WO2020076897A1
(en)
|
2018-10-09 |
2020-04-16 |
Genecentric Therapeutics, Inc. |
Detecting cancer cell of origin
|
WO2020104482A1
(en)
|
2018-11-20 |
2020-05-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting metastatic potential in patients suffering from sdhb-mutated paraganglioma
|
WO2021188611A1
(en)
|
2020-03-18 |
2021-09-23 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for treating subjects having a heterozygous alanine-glyoxylate aminotransferase gene (agxt) variant
|
EP3907301A1
(de)
|
2020-05-08 |
2021-11-10 |
Istituto Europeo di Oncologia S.r.l. |
Methoden und kits zur bestimmung des risikos eines erneuten auftretens von brustkrebs
|
WO2023122758A1
(en)
|
2021-12-22 |
2023-06-29 |
Cornell University |
Prognostic/predictive epigenetic breast cancer signature
|